-
Zane Andrews, PhD
… Dr Andrews gained his PhD degree from the University of Otago. He received post-doctoral …
-
Nadav Navon, PhD/MBA
… has a PhD in inorganic and analytical chemistry and an MBA from Ben-Gurion University in Israel. …
-
Marco Bortolato, MD, PhD
… Dr. Bortolato earned both a doctorate and a medical degree from the University of Cagliari, Italy. …
-
What We Fund: $85.9M Toward Research on a Wearable Device, Novel Therapeutics, Biomarkers and Much More
February 23, 2024
… preclinical testing of IRL757 and now, with funding from the MJFF Parkinson’s Disease Therapeutics Pipeline … activity and improve cognition . With supplemental funding from the MJFF Accelerated Therapeutics Program, they now are … to achieving that goal. With a supplemental research grant from MJFF, they are conducting clinical studies of a …
-
TFEB and Its Associated MicroRNA-128 as Targets for Neuroprotection and Disease Intervention in Parkinson´s Disease
… function and protect the affected dopamine neurons from alpha-synuclein-induced toxicity. Project Description: … of Parkinson’s Disease: Studies of brains from PD patients have shown a reduction of markers related … In addition, examination of post-mortem midbrain tissue from PD and control patients revealed changes in TFEB …
-
LRRK2 G2019S Disease Penetrance Modifiers
… development of Parkinson’s disease at very different ages, from early thirties to late eighties. In this proposal, we … aims to identify all genetic variation in 16 individuals from three different families that present the LRRK2 G2019S … age at disease onset in additional LRRK2 G2019S carriers from the same population. Relevance to Diagnosis/Treatment …